AI assistant
Sending…
GRI Bio, Inc. — Director's Dealing 2023
Apr 25, 2023
35409_dirs_2023-04-24_6a231cae-2cd1-4a5c-ad0a-b279b5c0b56c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: GRI BIO, Inc. (GRI)
CIK: 0001824293
Period of Report: 2023-04-21
Reporting Person: Szekeres David Leslie (Director)
More from GRI Bio, Inc.
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 4
Capital/Financing Update
2026
Jan 30
Capital/Financing Update
2026
Jan 30
Annual Report
2026
Jan 30
Regulatory Filings
2026
Jan 28
Capital/Financing Update
2026
Jan 21
Delisting Announcement
2026
Jan 16